Behcet Oral Ulcer Prophylaxis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Colchicine
BSR/BAD 2024: Colchicine first-line for mucocutaneous Behcet. Topical therapies for individual ulcers. AZA second-line. Apremilast evidence from RELIEF trial. The clinical context makes this the single best answer among the listed alternatives.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions